Perrigo Company PLC
NYSE:PRGO
Perrigo Company PLC
Revenue
Perrigo Company PLC
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Perrigo Company PLC
NYSE:PRGO
|
Revenue
$4.7B
|
CAGR 3-Years
4%
|
CAGR 5-Years
0%
|
CAGR 10-Years
2%
|
|
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
|
Revenue
$3.8B
|
CAGR 3-Years
17%
|
CAGR 5-Years
15%
|
CAGR 10-Years
16%
|
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
Revenue
$28m
|
CAGR 3-Years
8%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
21%
|
|
G
|
GH Research PLC
NASDAQ:GHRS
|
Revenue
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Cosmo Pharmaceuticals NV
SIX:COPN
|
Revenue
€96.7m
|
CAGR 3-Years
17%
|
CAGR 5-Years
8%
|
CAGR 10-Years
6%
|
|
Ovoca Bio PLC
LSE:OVB
|
Revenue
€0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Perrigo Company PLC
Revenue Breakdown
Breakdown by Geography
Perrigo Company PLC
Total Revenue:
4.7B
USD
|
United States:
2.9B
USD
|
Europe:
1.6B
USD
|
All Other Countries:
116.3m
USD
|
Ireland:
40.8m
USD
|
Breakdown by Segments
Perrigo Company PLC
Total Revenue:
4.7B
USD
|
Csca:
3B
USD
|
Csci:
1.7B
USD
|
See Also
What is Perrigo Company PLC's Revenue?
Revenue
4.7B
USD
Based on the financial report for Dec 31, 2023, Perrigo Company PLC's Revenue amounts to 4.7B USD.
What is Perrigo Company PLC's Revenue growth rate?
Revenue CAGR 10Y
2%
Over the last year, the Revenue growth was 5%. The average annual Revenue growth rates for Perrigo Company PLC have been 4% over the past three years , and 2% over the past ten years .